IPA 5 project activities
Preparing IPA (Instrument of Pre-accession Assistance) beneficiary countries for their participation in the work of the EMCDDA.
IPA 5 beneficiary countries are Albania, Bosnia-Herzegovina, the former Yugoslav Republic of Macedonia, Kosovo*, Montenegro and Serbia.
Timetable: July 2015–June 2017
Objective: the overall objective is to support the IPA beneficiaries in their preparation for participation in the work of the EMCDDA and the Reitox network.
In order to achieve this, the project has defined a set of measurable, specific objectives:
- To consolidate the Institutional framework of the cooperation.
- To foster scientific cooperation in relation to data collection, analysis and interpretation.
- To develop, increase and promote the added value of the cooperation.
EMCDDA-IPA5 final conference, Sarajevo, Bosnia and Herzegovina, 20–21 June 2017
To mark the end of the EC-funded EMCDDA-IPA5 project in June 2017, the EMCDDA is organising, with the support of the Ministry of Security of Bosnia and Herzegovina, a final conference in Sarajevo, that will bring together the EMCDDA national correspondents of the project beneficiaries (Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Kosovo*, Montenegro and Serbia), the national experts who contributed to the projects, EU Delegations and international organisations, in order to review the results of the IPA5 project.
The forthcoming EMCDDA-IPA6 project will also be announced at the conference.
Annual EMCDDA expert meeting on the drug-related infectious diseases (DRID) indicator, EMCDDA, Lisbon, 14–16 June 2017
This year’s annual drug-related infectious diseases (DRID) expert meeting was organised back-to-back with the 4th meeting of the ECDC hepatitis B and C network in Lisbon, with a joint meeting on 14 June. The main topics discussed at the DRID meeting were outbreaks, incidents and emerging risks, updates on the prevalence of infections, behavioural studies, responses, and the follow-up of the assessment of the implementation of the DRID key indicator. Experts from Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia and Serbia attended this meeting
National seminar ‘New psychoactive substances: methods for analysis of markets and new trends’, Tirana, Albania, 13–14 June 2017
The meeting was organised by the EMCDDA in close cooperation with the Institute of Public Health of Albania. The main purpose of this seminar was to inform national participants on the role of new psychoactive substances in Europe, the monitoring and control challenges, and to share best practices and available solutions, with an overall objective to enhance exchange of information on NPS in Albania. More than 20 participants attended this two-day meeting.
Drug seizures data collection training (standard table 13) in Sarajevo, Bosnia and Herzegovina, 13 June 2017
Following the EMCDDA conference in Sarajevo on 22 February last – and the decision by the Bosnian authorities to adopt the EMCDDA standard protocol to collect and analyse data on drug seizures – this technical training exercise focused on preparing the data managers from all the cantons and entities to begin collecting data on national drug seizures using standard table 13, in line with the EMCDDA protocol, from July 2017 onwards. This training was attended by 21 national experts from 15 police agencies and was organised by the EMCDDA in close collaboration with the Ministry of Security of Bosnia and Herzegovina..
Mid-term evaluation of the Serbian National Strategy on Drugs, Belgrade, Serbia, 12–16 June 2017
Two coaches representing the EMCDDA met with several national authorities in Belgrade for an on-site assessment regarding the Serbian National Strategy on Drugs. Among other tasks, the experts reviewed the final structure of the strategy and the key questions for the interviews with the relevant authorities. They also discussed the implementation of the policy for combating drug use.
Drug seizures data collection training (standard table 13) for Montenegrin participants, EMCDDA, Lisbon, 9 June 2017
This training was organised by the EMCDDA in response to a request from Montenegrin law enforcement authorities for a specific training on drug seizures data collection. The training focused on standard table 13 (ST 13) of the protocol on drug seizures, with the objective of describing the characteristics and trends of drug seizures reported by the EU Member States in order to improve the understanding of drug markets and supply-reduction activities and to report the information in a standardised way. The objective of the sub-indicator is to collect accurate, reliable, comparable and high-quality data on drug seizures that will help to understand the supply side of the drug phenomenon, assess the drug situation, the dynamics of the illicit drug market and the effectiveness of supply-oriented policies.
Annual EMCDDA expert meeting on the problem drug use (PDU) indicator, EMCDDA, Lisbon, 7–8 June 2017
The problem drug use (PDU) annual expert meeting brings together experts from EU Member States and third countries. It is an opportunity for the network to come together, to review its activities and to exchange information on latest studies and methods related to the PDU indicator. In 2017, the theme of the meeting was ‘consolidate, innovate, integrate’. Representatives of Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro and Serbia attended the meeting.
Seminar on new psychoactive substances (NPS), Banja Luka, Bosnia and Herzegovina, 8 June 2017
The seminar on new psychoactive substances (NPS) was organised by the EMCDDA in close cooperation with the Ministry of Interior of the Republic of Srpska and the Ministry of the Security of Bosnia and Herzegovina. The meeting was hosted in the Police Academy of the Republic of Srpska, in Banja Luka. The main objectives of this seminar were to increase awareness on NPS among practitioners in the health sector and other professionals, to discuss the situation with availability and accessibility of NPS in the country and to discuss health-related effects and responses to NPS. Around 50 experts from all over Bosnia and Herzegovina attended the meeting..
Annual EMCDDA expert meeting on the epidemiological indicator ‘Patterns and trends in drug use’ (GPS indicator), EMCDDA, Lisbon, 6–7 June 2017
The general population survey (GPS) annual expert meeting brings together EU Member States and third countries, projects and institutions. These regular meetings on the indicator change their focus from year to year. This year, particular attention was given to methodological developments on the indicator, the link between drug use surveys and drug policies, and targeted surveys in drug use, while serving as a platform for discussion on drug use issues. The meeting was attended by IPA beneficiary countries, who shared results of recent surveys conducted in their countries with the whole experts network. Representatives of Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Montenegro and Serbia attended the meeting.
Train the trainers meeting on the treatment demand indicator (TDI), Sarajevo, Bosnia and Herzegovina, 23 May 2017
This meeting, co-organised by the EMCDDA and the national authorities, gathered in Sarajevo all partners from the state level, the entities and some local organisations. There were about 30 participants, representatives of the Ministries of Health, public health institutes, treatment centres and therapeutic communities. The agenda was devoted to the implementation of the EMCDDA TDI v3 protocol with the aim at improving the treatment monitoring system in the country. The training included discussion on the case definitions and all the variables included in the TDI protocol and served to share best practices on data collection and treatment data analysis. The participants agreed to convene more frequent meetings on this topic to follow up on the implementation of the indicator.
Results analysis of the EMCDDA-IPA5 project on the European facility survey questionnaire (EFSQ), Tirana, Albania, 3–4 May 2017
Following the Reitox academy for IPA beneficiaries on ‘How to carry out a facility survey with the European facility survey questionnaire (EFSQ)’ organised by the EMCDDA in 2016, it was time for the involved experts, including UNODC representatives, to report on the accomplishments of the project’s implementation in the different countries. The meeting aimed at analysing the results of the EFSQ collected in early 2017 in the IPA beneficiary countries and at reviewing the reporting template for the national results and the regional report. These results will be presented the EMCDDA-IPA5 final conference, which will take place on 21 June in Sarajevo. The EMCDDA–UNODC ‘Joint regional report’ on the treatment facilities will be published during the second half of 2017.
Reitox Academy for IPA beneficiaries on the ‘Methods for detection of new psychoactive substances (NPS) and the role of forensic laboratories in the national early warning system (EWS)’, Budapest, Hungary, 4–6 April 2017
This Reitox Academy was organised by the EMCDDA in close cooperation with the Hungarian Institute for Forensic Sciences and the Hungarian national focal point. The objective of the training was to provide participants with knowledge on how to detect and analyse most common groups of new psychoactive substance (NPS; protocols, methods or networks for generation of standard samples), and to discuss the role of forensic laboratories within the national EWS. Fifteen experts from all six countries participating in the EMCDDA IPA5 project (2015–17) got a further insight into the criteria and diverse requirements to be met when performing an NPS analysis, discussed the chemistry of NPS and international guidelines and available analytical techniques for their identification in seized and biological materials. The participants also visited laboratories to familiarise themselves with the facilities, equipment and methodologies used in this field and encouraged discussions on possible future developments. The majority of participants were satisfied with the results of the training and the opportunity to share experiences and to interact with other experts and trainers.
Visit of a Serbian delegation to NGO ‘Check it!’, Vienna, Austria, 10–11 March 2017
The Ministry of Health of Serbia (MoH) requested the EMCDDA to support a study visit to ‘Check it!’, an Austrian NGO (funded by the Municipality of Vienna), which in partnership with the University toxicology laboratory (located in the General University Hospital of Vienna) provides on-site drug testing for synthetic stimulants and designer drugs at various music festivals. The overall aim of this programme is to provide people who may consider taking an illicit psychoactive substance with objective information on the content and the potential risks of use. The Ministry of Health of Serbia requested the visit to explore the possibility for setting up a similar programme in Zaječar, where one of the largest music festivals in the region is held. The delegation consisted of a representative of the MoH, the head of the reference laboratory for the psychoactive substances of the University and the NGO Timok Youth Centre. The participants visited the ‘Check-it!’ base and had an opportunity to participate in and observe the implementation of the programme at a music festival in Vienna.
Seminar on ‘Tools for monitoring drug-related issues: general population survey (GPS)’, Sarajevo, Bosnia and Herzegovina, 22–23 February 2017
The meeting focused on preparing the national working group for the implementation of a general population survey on drug use (GPS). This survey if carried out in the future would be the first global survey on drug use in the country and would provide the national stakeholders with information on the prevalence of drug use among the general population. The seminar focused on the methodological aspects of general population surveys, e.g. the European model questionnaire, field data collection, data quality and reporting.
Workshop on ‘Collection, analysis and appraisal of drug seizure data’, Sarajevo, Bosnia and Herzegovina, 22–23 February 2017
The workshop was organised in close cooperation with the Ministry of Security, with the aim at assisting the relevant national experts in supply and data collection to collect, analyse and appraise national drug seizures according to the EMCDDA protocol. Participants were encouraged to report on the data collection processes carried out by their institutions for the years 2011 to 2015, and 2016 when available. The workshop was preceded by several meetings between the EMCDDA staff members and the authorities of the Republic of Srpska, namely the EU Delegation Office in Banja Luka, the Ministry of Interior of the Republic of Srpska, the Institute of Public Health of the Republic of Srpska and the psychiatric ward of the Banja Luka Clinic Centre.
Following this workshop, the representatives present agreed to adopt the EMCDDA standard table data collection tool on drug seizures at all levels in Bosnia and Herzegovina from 1 July 2017 onwards. They stated, however, the need to receive a technical training, preferably before the beginning of July, aiming at helping the data managers from all the different entities and cantons of Bosnia and Herzegovina to use the data collection tool in line with the EU standard.
Reitox academy for IPA beneficiaries on ‘How to carry out a facility survey with the European facility survey questionnaire (EFSQ)’, EMCDDA, Lisbon, 13–14 December 2016
The objectives of this two-day workshop were to provide national experts with the necessary methodological and technical knowledge to carry out a treatment facility survey with a nationally-adapted version of the European Facility Survey Questionnaire. The workshop covered three main aspects: theory, methods and technical issues.
Support to the national early warning system (EWS), Albania, 1–2 December 2016
The EMCDDA, in cooperation with the Institute of Public Health, organised a meeting of national stakeholders as a first step towards the establishment of a national EWS and to discuss activities aimed at the implementation of the EU Council decision on the information exchange, risk assessment and control of new psychoactive substances.
ESPAD Assembly, EMCDDA, Lisbon, 27–29 November 2016
The ESPAD Assembly meeting was attended by representatives from Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Kosovo, Montenegro and Serbia. The IPA5 project ensures the participation of the ESPAD coordinators from these countries at the meeting, which took place from 27 to 29 November. Some of the most important topics discussed were related to the review of and reflections on the 2015 study, the use of ESPAD and school surveys for informing policy-making and interventions and for other purposes.
5th Extended RTX Week and 55th Reitox HFP meeting, EMCDDA, Lisbon, 21–22 November and 23–25 November 2016
Every year, the EMCDDA gathers the representatives of the Reitox network and of candidate, potential candidate and neighbouring countries in the Extended Reitox Week. This five-day meeting begins with a coordination meeting between non EU partner countries and the EMCDDA in order to discuss the progress to date and the further needs of those countries in the framework of the ongoing projects. On the second day, Reitox Network countries and non EU countries get together to exchange information on practical and thematic issues linked to the monitoring of the drug situation at national and European level. This year, the joint meeting was dedicated to the topic ‘Drugs and recreational settings’. The following days are designed for the participation of Reitox Network countries only.
Support to the national early warning system (EWS), Kosovo*, 29–30 November 2016
The EMCDDA, in cooperation with the Ministry of Interior, organised a meeting of national stakeholders as a first step towards the establishment of a national EWS and to discuss activities aimed at the implementation of the EU Council decision on the information exchange, risk assessment and control of new psychoactive substances.
Support to the national early warning system (EWS), Skopje, former Yugoslav Republic of Macedonia, 15–16 November 2016
Together with the national focal point at the Ministry of Health, the EMCDDA organised a meeting to discuss the implementation of the EU Council decision on the information exchange, risk assessment and control of new psychoactive substances and to develop activities to strengthen and expand the national expert networks
Support to the national early warning system (EWS), Sarajevo, Bosnia and Herzegovina, 2–4 November 2016
The EMCDDA, assisted the Ministry of State Security of Bosnia and Herzegovina in organising a meeting of national stakeholders as a first step towards the establishment of a national EWS and to discuss activities aimed at the implementation of the EU Council decision on the information exchange, risk assessment and control of new psychoactive substances.
Support to the national early warning system (EWS), Belgrade, Serbia, 27–28 October 2016
An EMCDDA delegation composed of two staff members and an EU expert (coach) met with representatives of the Ministry of Health, Ministry of Interior, Ministry of Justice and several governmental and non-governmental organisations, in order to discuss the progress made in formalising the national EWS and to develop activities to strengthen and expand the national expert networks
Reitox regional academy for candidate countries (CC) and potential candidate countries (PCC) of the European Union (EU) on collection, analysis and appraisal of drug seizure data, Vienna, Austria, 4–5 October 2016
This two-day training seminar took place at the Fundamental Rights Agency in Vienna and was attended by all of the beneficiary countries of the EMCDDA–IPA5 project. The objective of the training was to provide an insight into the types of information that policymakers and stakeholders require when considering action in terms of national policy and the development of appropriate strategies and operations to prevent and respond to drug use and trafficking. Countries were requested to collect national data, particularly on drug seizures, covering the period of 2011–2015 and submit it to the international consultant by 16 November 2016. A comprehensive report, providing the results of this project, is expected to be available by March 2017.
IPA5 project coordination meeting, Budva, Montenegro, 23 September 2016
After reaching approximately the middle of the EMCDDA-IPA5 project, it was necessary to assess the progress made to date by the beneficiary countries and to define the objectives for the period until the end of the project in June 2017. For this purpose, the EMCDDA held a meeting attended by the representatives of Albania, the former Yugoslav Republic of Macedonia, Kosovo, Montenegro and Serbia. The meeting was also attended by the EU delegations to Montenegro and Bosnia and Herzegovina.
PDU expert meeting, EMCDDA, Lisbon, 20–21 June 2016
The objectives of this year’s expert meeting on the Problem drug use (PDU) indicator were to consolidate the PDU network and core estimates, such as people who inject drugs and high-risk opioid use, to integrate the PDU indicator with other indicators in order to better address public health priorities, to explore new ways to complement traditional national estimates with other data sources and approaches and to identify capacity building needs. As a result of data sharing between the countries participating, a compilation of national abstracts was also made available online. In the framework of the IPA5 project, delegates from all candidate and potential candidate countries were also invited to participate. Those attending the meeting this year were Albania, Bosnia and Herzegovina (with the presence of one expert from the Republika Srpska), Kosovo, the former Yugoslav Republic of Macedonia, Montenegro and Serbia.
TDI meeting in Serbia, Belgrade, 20–21 June 2016
Software for the collection of Treatment demand indicator (TDI) data, called proTDI, was developed in cooperation with the twinning project during 2013 and 2014 and distributed to nearly 30 centres for routine data collection. The objective of this meeting was to improve the existing data collection system and to plan further steps for the implementation of the TDI in Serbia. The meeting also included a study visit to a treatment centre in Nis.
GPS expert meeting, EMCDDA, Lisbon, 19–20 June 2016
This year’s meeting of the general population survey (GPS) indicator focused on patterns, prevalence and trends in general, the European Model Questionnaire (EMQ) modules for monitoring alcohol use, new psychoactive substances and perceived availability. More than forty countries provided national status reports on the GPS indicator in their countries by sharing data, which were later compiled in an online publication called ‘2016 compilation of national abstracts’. In the framework of the IPA5 project, delegates from all candidate and potential candidate countries were also invited to participate. Those attending the meeting this year were Albania, Bosnia and Herzegovina (with the presence of one expert from the Republika Srpska), Kosovo, the former Yugoslav Republic of Macedonia, Montenegro and Serbia.
DRID 2016 expert meeting, EMCDDA, Lisbon, 6–8 June 2016
The Drug-related infectious diseases (DRID) network is composed of nominated experts from the 28 EU Member States, Norway and Turkey. Every year, they meet with members of public health institutes, international organisations and partners of other agencies to share the latest events in the field. Delegates from all candidate and potential candidate countries were also invited in the framework of the IPA5 project. The countries attending the meeting this year were Albania, Bosnia and Herzegovina (with the presence of one expert from the Republika Srpska), Kosovo, the former Yugoslav Republic of Macedonia and Serbia.
EWS expert meeting, EMCDDA, Lisbon, 19–20 May 2016
The 16th annual meeting of the Reitox Early Warning System (EWS) network took place in conjunction with the 5th law enforcement expert meeting on new psychoactive substances. On the second day of the event, there was a roundtable organised for the experts from the candidate and potential candidate countries that attended the meeting (Bosnia and Herzegovina, Kosovo, the former Yugoslav Republic of Macedonia, Montenegro and Serbia), with the objective of exchanging views on the status of the implementation of a national EWS in their countries.
High-level visit of the Ministry of Internal Affairs of Kosovo* to the EMCDDA, Lisbon, 26–27 April 2016
Following interest expressed in March 2016 by Kosovo’s authorities to further discuss issues related to the implementation of an Early warning system in the country, risk assessment on new psychoactive substances and drug laws in Europe, the EMCDDA invited a delegation, headed by the Deputy Minister of Internal Affairs, to a meeting at its premises. The delegation also included other members of the Ministry of Internal Affairs, as well as a representative of the Kosovo Police and the NGO ‘Labyrinth’. During the second day of the visit, the delegation met with the Director of the Portuguese General Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD) – where the Portuguese national focal point is located – and also visited the Xabregas treatment centre in Lisbon.
Building a National Drug Observatory in Montenegro, Podgorica, 30–31 March 2016
This workshop in Montenegro was dedicated to National Drug Observatory (NDO) building and drug monitoring tools. There were representatives from different types of institutions, such as the Ministry of Health, Customs, the Institute of Public Health, the Ministry of Education, treatment centres, the prosecutor’s office and the EU Delegation. The participants were introduced to the work of the EMCDDA, including the collaboration with the network of Reitox national focal points.
A part of the meeting was also dedicated to population surveys, such as ESPAD on general population survey on drugs. The implementation of a further national representative surveys on drugs in Montenegro was discussed.
Launch of the new IPA 5 project in Kosovo*, Pristina, 15–17 March 2016
An EMCDDA delegation visited Pristina to meet with the National Coordinator for the Strategy against Narcotics in order to address the establishment as soon as possible of a drugs observatory in the country. The EMCDDA offered its support to assist Kosovo and its institutions in the field of drugs through advice and expertise in this matter. Moreover, the EMCDDA also met the Kosovo Agency for Medicinal Products, the Kosovo Forensic Agency, and the Ministry of Health. A future visit of representatives of the Ministry of Internal Affairs to the EMCDDA was proposed. The following priorities for cooperation were also highlighted during the visit; support to the development of a national Early Warning System, further strengthening of monitoring and reporting of supply data, monitoring availability and provision of drug treatment and providing assistance for the establishment of a national drug observatory.
Launch of the new IPA 5 project in Bosnia and Herzegovina, Sarajevo, 10–11 March 2016
This was the first meeting under the IPA 5 project that took place in Bosnia Herzegovina. The meeting focused mainly on the four activities selected at national level for further cooperation. The EMCDDA delegation met representatives of the Ministry of Civil Affairs, the Ministry of Security and several other institutions, such as the Forensic Laboratory, Ministry of Health IPH, NGOs, the Police, the Ministry of the interior and the United Nations Development Programme. Representatives of the Republic of Srpska and the EU Delegation were also present. The discussion focused on the future launch of a general population survey (GPS)in the country, as well as the organisation of training sessions and workshops in the field of the Treatment Demand Indicator.
Coordination meeting in the Former Yugoslav Republic of Macedonia, Skopje, 16–18 February 2016
The EMCDDA’s International cooperation sector had a three-day long visit to Skopje, to meet with the Deputy Minister of Health, the Head of the national focal point and the representatives of Ministry of Interior and also with the Customs Department in order to exchange views on the EMCDDA’s activities in the country. Further bilateral meetings to explain the role of the EMCDDA also took place during the visit, namely with representatives of the Interministerial Committee on Drugs, The Global Fund to Fight AIDS, Tuberculosis and Malaria, the Medical Faculty of the University St Kyril and Mephodiy, the Institute of Public Health, the World Customs Organization, toxicological clinics and the EU Delegation. The state of the art of ESPAD (the European School Survey Project on Alcohol and Other Drugs) in the country was also discussed. The meetings highlighted the following priority areas for cooperation; advancing on activities to estimate prevalence of drug use among general population survey, support to further developing of a national Early Warning System on new psychoactive substances, further developments in monitoring and reporting supply data in line with EMCDDA requirements and monitoring drug treatment availability and provision.
Reitox Academy ‘Establishing a national Early Warning System in Serbia’, Belgrade, 17 December 2015
Establishing a national Early Warning System (EWS) is among the key priorities of Serbia. The EMCDDA, together with the Drug Monitoring Centre under the Ministry of Health of Serbia, organised a first workshop in December 2015 gathering about 45 participants representing a wide range of governmental partners. These included the Ministry of Health, the Ministries of Justice, Education and Social Support, the Europol National Unit, Customs, the Border Authority, and also non-governmental partners, such as forensic laboratories, the national toxicology centre, the forensic medicine centre, the faculties of chemistry and pharmacology, the Institute of Public Health, drug treatment centres, the United Nations Office on Drugs and Crime Country Office and the EU Delegation. The participants discussed how new psychoactive substances (NPS), and their use, are monitored and controlled, and highlighted a need to further increase national laboratories’ capacities for the detection of NPS.
Launch of the new IPA 5 project in Albania, Tirana, 9–10 December 2015
The EMCDDA’s International cooperation sector co-organised a meeting in Tirana in order to exchange knowledge and practices between Albania and the EMCDDA on monitoring the drug phenomenon and identify potential areas for further cooperation. Albania produced a national report on the drug situation in the country in 2014 and plans to update it within the next year. In the meantime, the Albania working group will work on an updated Country overview to be made available on the EMCDDA website by the end of 2016. During the December visit, the EMCDDA met with representatives of the drug data collection, analysis and reporting entities within the Ministry of Health, the Ministry of the Interior and other relevant services working in the drugs field. A list of possible further activities to be co-organised was also drafted.
Fourth Extended Reitox Week, EMCDDA, Lisbon, 23–24 November 2015
The Extended Reitox Week is an annual meeting that gathers the members of the Reitox network (EU, Norway and Turkey) and the national correspondents from candidate, potential candidate and Neighbouring countries and from Russia, with the aim of exchanging experiences and know-how on issues linked to monitoring the drugs situation at national and European level. During the 2015 meeting, a special session will be dedicated to outlining cooperation activities with candidate and potential candidate countries for the next two years.
All IPA beneficiary countries are invited to attend. The countries will be represented by a national correspondent or the head of national focal point or their designated person. Country representatives of the Missions to the EU were also invited to attend the meeting.
ESPAD assembly meeting , Larnaca, Cyprus 15–17 November 2015
The European School Survey Project on Alcohol and Other Drugs is a cross-national research project aimed to collect comparable data on Alcohol and other Drugs around the world. Albania, the Former Yugoslav Republic of Macedonia and Montenegro took part to the 2015 ESPAD data collection, with their own funding. The IPA 5 project ensures the participation of the ESPAD coordinators from these countries at the assembly meeting, taking place on 15–17 November 2015. The meeting will focus on the 2015 data collection.
Launch of the new IPA5 project in Montenegro, Podgorica, 14 October 2015
The International cooperation sector staff attended a one-day meeting in Podgorica to discuss the new project with the Assistant Health Minister and the Montenegrin national correspondent. The Assistant Minister of Health recalled Montenegro’s commitment to participate in the new project. Meetings with the Ministry of the Interior, the Public Institute of Public Health and other international organisations were also organised. The meetings contributed to the identification of the priorities for Montenegro, including an evaluation of the country’s Drug Strategy, the improvement of its data collection system, the development of an EWS at national level, training sessions, the implementation of surveys and coordination mechanisms, among other activities. A list of first activities that will be co-organised has been following the event.
Experts from candidate and potential candidate countries attended the ‘Lisbon Addictions Conference’, FIL meeting centre, Parque das Nações, 23–25 September 2015
This new event in the addictions calendar was organised by the Portuguese General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD — Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências) in collaboration with the EMCDDA.
Top international and European addiction experts presented new findings on illicit drugs, alcohol, tobacco, gambling and other addictive behaviours. There were also multi-disciplinary workshops and discussion forums, covering epidemiology, policy research, clinical research, social sciences, behavioural science and human psychopharmacology.
The participation of experts from Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Kosovo*, and Serbia was financed by IPA 5 project funds.
Experts from Candidate and potential candidate countries attend the ‘20years of monitoring and communicating evidence on drugs’ conference, EMCDDA, Lisbon, 21–22 September 2015
Representatives of Albania, Bosnia and Herzegovina, the former Yugoslav Republic of Macedonia, Kosovo*, Montenegro and Serbia, attended the 20 years of monitoring and communicating evidence on drugs conference, together with the members of the EU national focal points and several experts. This special EMCDDA technical conference aimed to reflect on the lessons learned during the last 20 years of monitoring drug use and how the EMCDDA will meet the future challenges of continuing to provide Europe with a robust understanding of the extent and nature of drug use and drug problems.
Launch of the new IPA5 project in Serbia, Belgrade, 16–17 September 2015
Staff from the International cooperation sector attended a one-day meeting in Belgrade to discuss the new project with the Assistant Health Minister and the Serbian national correspondent. The meeting helped identify the priorities for Serbia which include, for example, the improvement of the data collection system, the development of an EWS at national level, training sessions, the implementation of surveys and coordination mechanisms. A list of first activities that will be co-organised was drafted following the event.
* This designation is without prejudice to positions on status, and is in line with UNSCR 1244 and the ICJ Opinion on the Kosovo declaration of independence. This applies to all mentions of Kosovo in this document.